Pharma & Biotech
Featured Client Results
Pharma & Biotech
Biopharma Genomic Testing Market Research
Minimal Residual Disease (MRD) Application Prioritization and Evidence Generation Strategy
Methylation Analysis Opportunity Identification for Ultra-Sensitive Detection Platform
View All Client Results
Data & Platforms
Spatial Biology + Digital Pathology Competitive Intelligence Report - H1 2022
Global Oncology Liquid Biopsy Manufacturing Market
Oncology Biomarker Market Assessment
Single Cell Genomics Market Assessment
Life Science Research Tools Market Assessment
Next Generation Sequencing (NGS) Market Assessment & Trends
Dexter Expert Network
View All Data & Platforms
Meet the Team
In The Press
The Precision Medicine Revolution Will Be Driven By Diagnostic Technologies
July 12, 2022
Liquid Biopsy | July Roundup
July showcased new partnerships, product launches, clinical trials, and study result updates in liquid biopsy.
August 8, 2022
ctDNA MRD and Monitoring Front and Center at ASCO 2022
ctDNA MRD and monitoring was front and center at ASCO 2022. We analyzed 19 abstracts published by leading commercial players.
August 2, 2022
Introduction to MtDNA: A Burgeoning Biomarker in Cancer
With the rapid growth of liquid biopsy research, biomarkers like mtDNA, in addition to more “traditional” analytes (e.g., ctDNA, cfDNA, proteins), are being pursued.
July 15, 2022
Liquid Biopsy | June Roundup
Liquid Biopsy (LBx) in June was spearheaded by novel company partnerships and product launches as well as clinical trial launches and validation study result updates.
July 11, 2022
View All Insights
Precision Medicine is evolving at a rapid pace
Discover how we can help
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Precision Medicine. Precision Insights.
© DeciBio 2022. All rights reserved.
Terms & Conditions